Apolipoprotein E genotype: Utility in clinical practice in Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 44, Issue 12, 1996, Pages 1469-1471

  Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

ALLELE; ALZHEIMER DISEASE; ARTICLE; ATHEROGENESIS; CHOLESTEROL TRANSPORT; DEMENTIA; GENOTYPE; INCIDENCE; INHERITANCE; LIPID METABOLISM; RISK FACTOR;

EID: 0029819963     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb04073.x     Document Type: Article

References (22)

1. Ordovas JM, Litwack-Klein L, Wilson PWF et al. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987;28:371-380.
2. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: High-aviditiy binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
3. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
4. Rebeck GW, Reiter JS, Strickland DK et al. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993;11:575-580.
5. Poirier J, Davignon J, Bouthillier D et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
6. Corder EH, Saunders AM, Risch NJ et al. Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease. Nature Genet 1994;7:180-184.
7. West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E ∈2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 1994;175:46-48.
8. Mayeux R, Stern Y, Ottman R et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
9. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
10. Hyman B, Gomez-Isla T, Briggs M et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;39:55-66.
11. Feskens E, Havekes L, Kalmijn S et al. Apolipoprotein E and cognitive decline in elderly men. Br Med J 1994;309:1202-1206.
12. Kuusisto J, Koivisto K, Kervinen K et al. Association of apolipoprotein E with late onset Alzheimer's disease: Population based study. Br Med J 1994;309:636-638.
13. Henderson A, Easteal S, Jorm A et al. Apolipoprotein E allele 4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-1390.
14. Myers R, Schaefer E, Wilson P et al. Apolipoprotein E ∈4 association with dementia in a population based study: The Framingham study. Neurology 1996;46:673-677.
15. Rebeck GW, Perls TT, West HL et al. Reduced apolipoprotein E4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-1516.
16. Gomez-Isla T, West HL, Rebeck GW et al. Clinical and pathological correlates of apolipoprotein E ∈4 in Alzheimer disease. Ann Neurol 1996;39:62-70.
17. Gearing M, Schneider JA, Rebeck GW et al. Alzheimer's disease with and without coexisting Parkinson's disease changes: Apolipoprotein E genotype and neuropathological correlates. Neurology 1995;45:1985-1990.
18. Mui S, Rebeck GW, McKenna-Yasek D et al. Apolipoprotein E ∈4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 1995;380:460-463.
19. Waring S, Rocca W, Smith G et al. Apolipoprotein E and rate of clinical progression in Alzheimer's disease. Neurology 1996;46:A348.
20. Growdon J, Locasio J, Corkin S et al. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;46:A419.
21. Farlow M, Lahiri D, Hui S et al. Apoliporotein E genotype predicts response to tacrine in Alzheimer's disease. Neurology 1996;46:A217.
22. Amouyel P, Neuman E, Dillemann L et al. Characterization of the apolipoprotein E genotypes in a European multicenter trial with the S-12024-2 memory enhancer. Neurology 1996;46:A218.